ACHIEVE LIFE SCIENCES INC (ACHV) — insider trading
Health Care · NASDAQ
ACHIEVE LIFE SCIENCES INC (ACHV) has 24 reported SEC Form 4 insider transactions in our data, including 1 open-market sale among the most recent 24 (latest 2026-10-05).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Halladay Benjamin | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 200,000 | — | $0 | Form 4 |
| 2026-10-05 | Halladay Benjamin | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 200,000 | — | $0 | Form 4 |
| 2026-08-19 | Stewart Richard Alistair | Director | Open-market sale | 20,626 | $8.49 | $175.2K | Form 4 |
| 2026-07-27 | Phelan Nancy R. | Director | Grant / award / vesting (derivative) | 16,700 | — | $0 | Form 4 |
| 2026-07-27 | Phelan Nancy R. | Director | Grant / award / vesting (derivative) | 25,000 | — | $0 | Form 4 |
| 2026-07-27 | Farrow Jeffrey S | Director | Grant / award / vesting (derivative) | 16,700 | — | $0 | Form 4 |
| 2026-07-27 | Farrow Jeffrey S | Director | Grant / award / vesting (derivative) | 25,000 | — | $0 | Form 4 |
| 2026-07-27 | Stewart Richard Alistair | Director | Grant / award / vesting (derivative) | 16,700 | — | $0 | Form 4 |
| 2026-07-27 | Stewart Richard Alistair | Director | Grant / award / vesting (derivative) | 25,000 | — | $0 | Form 4 |
| 2026-07-27 | Waldman Reid Alexander | Director | Grant / award / vesting (derivative) | 16,700 | — | $0 | Form 4 |
| 2026-07-27 | Waldman Reid Alexander | Director | Grant / award / vesting (derivative) | 25,000 | — | $0 | Form 4 |
| 2026-07-27 | Royston Aaron | Director | Grant / award / vesting (derivative) | 16,700 | — | $0 | Form 4 |
| 2026-07-27 | Royston Aaron | Director | Grant / award / vesting (derivative) | 25,000 | — | $0 | Form 4 |
| 2026-07-27 | Martin Christopher Nathan | Director | Grant / award / vesting (derivative) | 16,700 | — | $0 | Form 4 |
| 2026-07-27 | Martin Christopher Nathan | Director | Grant / award / vesting (derivative) | 25,000 | — | $0 | Form 4 |
| 2026-07-27 | Sellig Thomas | Director | Grant / award / vesting (derivative) | 16,700 | — | $0 | Form 4 |
| 2026-07-27 | Sellig Thomas | Director | Grant / award / vesting (derivative) | 25,000 | — | $0 | Form 4 |
| 2026-05-29 | Farrow Jeffrey S | Director | Grant / award / vesting (derivative) | 47,250 | — | $0 | Form 4 |
| 2026-05-29 | Waldman Reid Alexander | Director | Grant / award / vesting (derivative) | 47,250 | — | $0 | Form 4 |
| 2026-05-11 | Martin Christopher Nathan | Director | Grant / award / vesting (derivative) | 47,250 | — | $0 | Form 4 |
| 2026-04-18 | Goldberg Andrew D. | Director, Officer (CEO and President) | Grant / award / vesting (derivative) | 11,706,270 | — | $0 | Form 4 |
| 2026-04-18 | Goldberg Andrew D. | Director, Officer (CEO and President) | Grant / award / vesting (derivative) | 3,601,929 | — | $0 | Form 4 |
| 2026-04-18 | Goldberg Andrew D. | Director, Officer (CEO and President) | Grant / award / vesting (derivative) | 1,800,965 | — | $0 | Form 4 |
| 2026-01-28 | Rubinstein Mark Lawrence | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 180,000 | — | $0 | Form 4 |
Ask the chat about ACHV's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ACHIEVE LIFE SCIENCES INC (ACHV).
Last updated 2026-10-05 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.